Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PD-1 Antibodies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07474064
What this trial is testing

Probiotics Combined With Targeted Therapy Plus Immunotherapy in Bladder-Preserving Setting for Patients With MIBC

Who this might be right for
Muscle Invasive Bladder Cancer (MIBC)
chenxu 146
Early research (Phase 1)Temporarily pausedNCT05155332
What this trial is testing

Test Different Doses of BI 1831169 Alone and in Combination With an Anti-PD-1 Antibody in People With Different Types of Advanced Cancer (Solid Tumors)

Who this might be right for
Solid Tumors
Boehringer Ingelheim 190
Large-scale testing (Phase 3)Not Yet RecruitingNCT07783321
What this trial is testing

Anti-PD-1 Antibody With or Without BL-B01D1 as Maintenance Therapy Following Anti-PD-1 Antibody Plus Chemotherapy for the First-line Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma (PANKU-NPC02)

Who this might be right for
Nasopharyngeal Carcinoma (NPC)
Sichuan Baili Pharmaceutical Co., Ltd. 404
Early research (Phase 1)UnknownNCT04564313
What this trial is testing

Safety and Efficacy of Camrelizumab (Anti-PD-1 Antibody) in Recurrent HCC After Liver Transplantation

Who this might be right for
Hepatocellular CarcinomaLiver Transplantation
Third Affiliated Hospital, Sun Yat-Sen University 20
Early research (Phase 1)Study completedNCT02838823
What this trial is testing

Safety and Tolerability of Recombinant Humanized Anti-PD-1 Monoclonal Antibody for Patients With Advanced Breast Cancer

Who this might be right for
Breast Cancer
Shanghai Junshi Bioscience Co., Ltd. 20
Early research (Phase 1)Looking for participantsNCT05142189
What this trial is testing

Clinical Trial Evaluating the Safety, Tolerability and Preliminary Efficacy of BNT116 Alone and in Combinations in Patients With Advanced Non-small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
BioNTech SE 320
Large-scale testing (Phase 3)Ended earlyNCT03866980
What this trial is testing

Anti-PD-1 AK105 in Patients With Metastatic Nonsquamous Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer Non-small Cell Stage IV
Akeso 164
Testing effectiveness (Phase 2)UnknownNCT02873390
What this trial is testing

PD-1 Antibody Expressing CAR-T Cells for EGFR Family Member Positive Advanced Solid Tumor

Who this might be right for
PD-1 AntibodyCAR-T CellsAdvanced Malignancies
Ningbo Cancer Hospital 20
Testing effectiveness (Phase 2)Looking for participantsNCT06793813
What this trial is testing

Cadonilimab in Patients (Pts) with Advanced Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Stage IVB Lung CancerNon-Squamous
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 44
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07820813
What this trial is testing

BNAbs and Anti-PD-1 in HIV

Who this might be right for
HIV-1
Ole Schmeltz Søgaard 90
Testing effectiveness (Phase 2)UnknownNCT04157491
What this trial is testing

Anti-PD-1 Antibody Combined With Anlotinib in the Treatment of Endometrial Cancer

Who this might be right for
Endometrial Cancer
Sun Yat-sen University 23
Testing effectiveness (Phase 2)UnknownNCT04108013
What this trial is testing

SHR-1210 in Combination With Carboplatin+Paclitaxel-albumin in Subjects With Resectable NSCLC

Who this might be right for
Lung Cancer Stage IIPD-1 AntibodyNon-small Cell Lung Cancer
Xuanwu Hospital, Beijing 38
Testing effectiveness (Phase 2)Study completedNCT03599713
What this trial is testing

INCMGA00012 in Metastatic Merkel Cell Carcinoma (POD1UM-201)

Who this might be right for
Metastatic Merkel Cell Carcinoma
Incyte Corporation 107
Not applicableUnknownNCT04782089
What this trial is testing

Study of PD-1 Antibody and PARP Inhibitor in Extensive Stage Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer
Qilu Hospital of Shandong University 20
Early research (Phase 1)Study completedNCT02407990
What this trial is testing

Study of the Safety, Pharmacokinetics and Antitumor Activities of BGB-A317 in Participants With Advanced Tumors

Who this might be right for
Advanced Cancer
BeiGene 451
Testing effectiveness (Phase 2)Ended earlyNCT02452424
What this trial is testing

A Combination Clinical Study of PLX3397 and Pembrolizumab To Treat Advanced Melanoma and Other Solid Tumors

Who this might be right for
MelanomaNon-small Cell Lung CancerSquamous Cell Carcinoma of the Head and Neck+2 more
Daiichi Sankyo 78
Testing effectiveness (Phase 2)Study completedNCT05254899
What this trial is testing

Tislelizumab, Chemotherapy, and Radiation Therapy for Early-Stage High-Risk ENKTCL (CLCG-2102)

Who this might be right for
Extranodal NK-T-Cell LymphomaEarly-stageHigh-Risk Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 54
Testing effectiveness (Phase 2)Study completedNCT03531632
What this trial is testing

MGD007 Combined With MGA012 in Relapsed/Refractory Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer Metastatic
MacroGenics 38
Testing effectiveness (Phase 2)UnknownNCT04337463
What this trial is testing

ATG-008 Combined With Toripalimab in Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
Sichuan University 60
Not applicableLooking for participantsNCT05878964
What this trial is testing

Evaluation of Skin Health and QoL in Pts Receiving Anti-PD1/PDL1/CTLA4 or CDK Inhibitors.

Who this might be right for
Lung CancerBreast CancerKidney Cancer+5 more
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 420
Next Page